At ReverseAge, we are at the forefront of groundbreaking research in the fields of anti-aging and inflammation reduction.


Founded in 2021  ReverseAge is a biotechnology company specializing in epigenetics research with the use of Artificial Intelligence. 


Our commitment to scientific excellence drives us to explore the most advanced methodologies and technologies. By partnering with top-tier laboratories in the United States and China, we harness a global pool of knowledge and expertise. This allows us to innovate and refine our products, ensuring they meet the highest standards of quality and efficacy.

  • SENOLYTICS

    Our primary area of focus is the exploration and development of senolytics. These are compounds designed to target and eliminate senescent cells, which accumulate with age and contribute to various age-related conditions.

  • CANCER TREATMENT

    We are investigating novel approaches to cancer treatment, emphasizing the reduction of cells that have undergone apoptosis. This research has the potential to lead to groundbreaking therapies that can significantly improve cancer outcomes.

  • REVERSING AGE

    In addition to senolytics, we are dedicated to discovering and developing drugs that can effectively reverse the signs of aging. Through rigorous testing and clinical trials, we aim to bring revolutionary anti-aging solutions to market.

  • SKINCARE

     We have worked diligently to develop advanced skincare products that leverage our research in anti-aging and epigenetics. These products are designed to enhance skin health, reduce the signs of aging, and promote a youthful appearance.